Literature DB >> 8349779

Ramoplanin susceptibility testing criteria.

A L Barry1, M A Pfaller, P C Fuchs.   

Abstract

Ramoplanin and mupirocin are two antimicrobial agents that may be applied topically. They had similar potencies against susceptible gram-positive cocci, but they differed in their spectra of activity. In plastic microdilution trays, the in vitro activity of ramoplanin was slightly diminished but that activity was restored by the addition of bovine serum albumin (0.02%). Susceptible strains were defined as those for which MICs of ramoplanin were < or = 2.0 micrograms/ml (without bovine serum albumin) and which had > or = 11-mm zones around 60-micrograms ramoplanin disks. Criteria for a resistant category cannot be defined at this time.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8349779      PMCID: PMC265664          DOI: 10.1128/jcm.31.7.1932-1935.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacin.

Authors:  A L Barry; J H Jorgensen; D J Hardy; S D Allen; C N Baker; P C Fuchs; J C McLaughlin
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

2.  Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic.

Authors:  P C Fuchs; R N Jones; A L Barry
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

3.  In vitro evaluation of ramoplanin (MDL 62198, A 16686)

Authors:  S Dixson; W Brumfitt; J M Hamilton-Miller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

4.  Transferable mupirocin-resistance.

Authors:  W C Noble; M Rahman; B Cookson; I Phillips
Journal:  J Antimicrob Chemother       Date:  1988-11       Impact factor: 5.790

5.  In vitro evaluation of ramoplanin (A16686 or MDL62198). A new depsipeptide complex for potential topical use.

Authors:  R N Jones; A L Barry
Journal:  Diagn Microbiol Infect Dis       Date:  1989 May-Jun       Impact factor: 2.803

6.  In-vitro studies with ramoplanin (MDL 62,198): a novel lipoglycopeptide antimicrobial.

Authors:  M D O'Hare; G Ghosh; D Felmingham; R N Grüneberg
Journal:  J Antimicrob Chemother       Date:  1990-02       Impact factor: 5.790

7.  Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus.

Authors:  P A Maple; J M Hamilton-Miller; W Brumfitt
Journal:  J Antimicrob Chemother       Date:  1989-04       Impact factor: 5.790

  7 in total
  7 in total

1.  Interpretive criteria for testing susceptibility of staphylococci to mupirocin.

Authors:  J E Finlay; L A Miller; J A Poupard
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

2.  Comparison of agar dilution, tube dilution, and broth microdilution susceptibility tests for determination of ramoplanin MICs.

Authors:  M T Kenny; M A Brackman
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

3.  Effect of polysorbate 80 on oritavancin binding to plastic surfaces: implications for susceptibility testing.

Authors:  Francis F Arhin; Ingrid Sarmiento; Adam Belley; Geoffrey A McKay; Deborah C Draghi; Parveen Grover; Daniel F Sahm; Thomas R Parr; Gregory Moeck
Journal:  Antimicrob Agents Chemother       Date:  2008-02-25       Impact factor: 5.191

4.  In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria.

Authors:  D M Citron; C V Merriam; K L Tyrrell; Y A Warren; H Fernandez; E J C Goldstein
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

5.  Resistance pattern of mupirocin in methicillin-resistant Staphylococcus aureus in trauma patients and comparison between disc diffusion and E-test for better detection of resistance in low resource countries.

Authors:  Nonika Rajkumari; Purva Mathur; Nidhi Bhardwaj; Gunjan Gupta; Rajrani Dahiya; Bijayini Behera; Mahesh Chandra Misra
Journal:  J Lab Physicians       Date:  2014-07

6.  Ramoplanin at bactericidal concentrations induces bacterial membrane depolarization in Staphylococcus aureus.

Authors:  Mu Cheng; Johnny X Huang; Soumya Ramu; Mark S Butler; Matthew A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

7.  Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays.

Authors:  Angela Kavanagh; Soumya Ramu; Yujing Gong; Matthew A Cooper; Mark A T Blaskovich
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.